Key result
Zero modifiable risk factors linked to ~20% lower in-hospital mortality in older STEMI patients.
Why the study?
Few studies have evaluated the management and outcomes of older patients without standard modifiable cardiovascular risk factors (SMuRFs) after myocardial infarction.
Does the absence of standard modifiable cardiovascular risk factors (SMuRFs-less) affect in-hospital treatment and all-cause mortality in patients aged ≥75 years presenting with a first STEMI?
Cohort (n=10,775)
Yes
Does the absence of standard modifiable cardiovascular risk factors (SMuRFs-less) affect in-hospital treatment and all-cause mortality in patients aged ≥75 years presenting with a first STEMI?
Answers are grounded in this paper and cite their sources.
Approximately 1 in 7 STEMI patients aged ≥75 years in China lack standard modifiable risk factors, and while their unadjusted in-hospital mortality matches patients with risk factors due to undertreatment, adjusting for guideline-directed therapies reveals a 20% lower mortality risk, underscoring the need to provide full evidence-based care regardless of risk factor status.
Strategies targeting standard modifiable cardiovascular risk factors (SMuRFs), including hypertension, diabetes, hypercholesterolemia, and smoking, have been well established to prevent coronary heart disease. However, few studies have evaluated the management and outcomes of older patients without SMuRFs after myocardial infarction. The authors sought to evaluate the profile of patients with ST-segment elevation myocardial infarction (STEMI) aged ≥75 years without SMuRFs. This study is based on the CCC-ACS (Improving Care for Cardiovascular Disease in China-Acute Coronary Syndrome) project. Patients aged ≥75 years with a first presentation of STEMI were enrolled in this study between November 2014 and December 2019. Modified Poisson regression was used to evaluate the association between SMuRF-less and in-hospital outcomes. Among 10,775 patients with STEMI aged ≥75 years, 1,633 (15.16%) had no SMuRFs. Compared with those with SMuRF, SMuRF-less patients received less evidence-based treatment. In-hospital mortality was similar among patients with and without SMuRFs (5.44% vs 5.14%; P = 0.630). However, after adjustment for patient characteristics and treatment, being SMuRF-less was significantly associated with a reduced risk of mortality (RR: 0.80; 95% CI: 0.65-0.99; P = 0.043). SMuRF-less patients also had a significantly reduced risk of in-hospital death when only adjusting for in-hospital treatment (RR: 0.78; 95% CI: 0.63–0.98; P = 0.030), regardless of patient characteristics. Approximately 1 in 7 STEMI patients in China ≥75 years old had no SMuRFs. The similar mortality in patients with and without SMuRF can be partially explained by the inadequate in-hospital treatment of SMuRF-less patients. The quality of care for older patients without SMuRF should be improved. (CCC Project–Acture Coronary Syndrome; NCT02306616)
No takes yet. Share an insight, caveat, or question.
Zhao et al. (2023) conducted a cohort in First presentation of ST-segment elevation myocardial infarction (STEMI) (n=10,775). Absence of standard modifiable cardiovascular risk factors (SMuRFs-less: no hypertension, diabetes, hypercholesterolemia, or current smoking) vs. Presence of ≥1 standard modifiable cardiovascular risk factor (SMuRF) was evaluated on In-hospital all-cause mortality (RR 0.80, 95% CI 0.65-0.99, p=0.043). Absence of standard modifiable risk factors in STEMI patients aged ≥75 years was associated with a 20% lower risk of in-hospital mortality after adjusting for characteristics and treatment.
Synapse has enriched 10 related papers. Consider them for comparative context: